Beth Weinberg
Consigliere Generale presso CARA THERAPEUTICS, INC.
Profilo
Beth Weinberg currently works at CARA Therapeutics, Inc., as Senior Vice President-Regulatory Affairs.
Ms. Weinberg also formerly worked at Angion Biomedica Corp., as Vice President & Head-Regulatory and Metavant Sciences, Inc., as VP, Head-Regulatory Affairs & Quality.
Ms. Weinberg received her undergraduate degree from Butler University and undergraduate degree from Bradley University.
Posizioni attive di Beth Weinberg
| Società | Posizione | Inizio |
|---|---|---|
| CARA THERAPEUTICS, INC. | Consigliere Generale | - |
Precedenti posizioni note di Beth Weinberg
| Società | Posizione | Fine |
|---|---|---|
| ANGN BIOM | Consigliere Generale | - |
| Metavant Sciences, Inc. | Consigliere Generale | - |
Formazione di Beth Weinberg
| Butler University | Undergraduate Degree |
| Bradley University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
| Metavant Sciences, Inc. |
- Borsa valori
- Insiders
- Beth Weinberg
